Preferred Name | remifentanil hydrochloride | |
Synonyms |
1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride Ultiva |
|
Definitions |
The hydrochloride salt form of remifentanil, a synthetic anilidopiperidine derivative and short-acting opiate agonist with analgesic and anesthetic properties. Remifentanil selectively binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47702" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47702" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000461218 |
|
altLabel |
1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride Ultiva |
|
CAS Registry |
132539-07-2 |
|
cui |
C0771827 C0594510 |
|
DATE FIRST PUBLISHED |
2005-12-22 |
|
Date last modified |
2007-09-19 |
|
definition |
The hydrochloride salt form of remifentanil, a synthetic anilidopiperidine derivative and short-acting opiate agonist with analgesic and anesthetic properties. Remifentanil selectively binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47702" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47702" NCI Thesaurus) |
|
LT |
TRD |
|
NCI ID |
C47702 |
|
notation |
CDR0000461218 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
remifentanil hydrochloride |
|
tui |
T109 T121 |